Streetbeat News

Revenues

VZ

Verizon forecasts a total wireless service revenue growth of 2-3.5% for the year 2024.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 12:05 pm

GFS

Analysts have varying opinions on GLOBALFOUNDRIES (NASDAQ:GFS), with recent ratings ranging from bullish to bearish. Over the last quarter, there were 4 somewhat bullish and 1 indifferent rating. The average 12-month price target is now $68.6, down from $75.00, with a high estimate of $75.00 and a low of $65.00. Analysts from firms like Cantor Fitzgerald, B of A Securities, Morgan Stanley, JP Morgan, and Susquehanna have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. GLOBALFOUNDRIES, a semiconductor manufacturer, faces challenges with a -10.7% revenue decline, below-average net margin, ROE, and ROA, but has a conservative debt-to-equity ratio of 0.25.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 12:01 pm

PWSC

PowerSchool Holdings (NYSE:PWSC) has been rated by 4 analysts in the last three months, with 3 somewhat bullish and 1 indifferent rating. The average 12-month price target is $27.5, up 3.77% from the previous $26.50. Analysts from Piper Sandler, UBS, RBC Capital, and Cantor Fitzgerald have provided recent evaluations, with price targets ranging from $25 to $30. PowerSchool Holdings is a cloud-based software provider for K-12 education, with a market cap below industry average, revenue growth of 12.15%, and strong profitability indicators like net margin, ROE, and ROA. Its debt-to-equity ratio is 0.66, indicating a sound financial structure.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 12:00 pm

BNTX

BioNTech (NASDAQ:BNTX) has received mixed analyst ratings over the past three months, with 5 analysts offering diverse perspectives. The average 12-month price target is now $116.6, down from $132.25, with a high estimate of $133.00 and a low of $99.00. Analysts from firms including HC Wainwright & Co., JP Morgan, and Morgan Stanley have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. BioNTech's financial performance shows a significant revenue decline of -74.13% over a 3-month period, but strong net margin and ROE/ROA figures. The company's debt-to-equity ratio is low at 0.01, indicating a conservative debt management approach.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 12:00 pm

RTX

RTX Company has reported a substantial backlog totaling $196 billion, with $118 billion attributed to commercial interests and $78 billion to defense contracts.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 11:57 am

ANIP

ANI Pharmaceuticals, Inc. has launched Pentoxifylline Extended-Release Tablets, USP 400 mg, a generic version of Trental. The U.S. market for this medication is estimated to be around $19.7 million annually, based on IQVIA/IMS Health data.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 11:53 am

DHI

DR Horton projects its consolidated revenues for 2024 to be between $36 billion and $37.3 billion, which is in line with the estimated $36.64 billion.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 11:32 am

DHI

D.R. Horton (NYSE:DHI) reported Q1 2024 earnings per share (EPS) of $2.82, missing the consensus estimate of $2.88 by 2.08%. However, the company's quarterly sales of $7.73 billion exceeded expectations of $7.60 billion by 1.71% and marked a 6.45% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 11:31 am

MMYT

MakeMyTrip Ltd reported a 21.7% year-over-year growth in gross bookings for Q3 FY24, reaching $2.09 billion, driven by robust travel demand.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 11:13 am

BABA

TCEHY

Richard Fontaine, CEO of the Center for a New American Security, argues that despite China's economic slowdown, demographic challenges, and real estate turmoil, the country still offers significant investment opportunities. China's economy outpaced the U.S. last year and leads in technologies like AI and quantum computing. The Chinese military is expanding, and there's no sign of economic struggles impacting its global activities. However, China's tech giants Alibaba (BABA) and Tencent (TCEHY) face economic headwinds, with reduced external investments and a global tourism hit of $129 billion due to post-pandemic pullback.

Portfolio Pulse from Benzinga Neuro

January 23, 2024 | 10:40 am